Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · KORU Medical Systems, Inc. (KRMD)

KORU Medical Q1 revenue rises 22% to $11.8 million; net loss narrows

Positive Impact 3 of 5 earnings Written later

KORU Medical Systems reported first quarter 2026 results, with net revenues up 22.1% to $11.8 million and net loss narrowing to $0.8 million from $1.2 million a year earlier. The company reiterated its full year 2026 guidance of $47.5 million to $50.0 million in net revenues, a gross margin of 61% to 63%, and positive adjusted EBITDA and cash flow.

Key points

  • Q1 2026 net revenues were $11.8 million, up 22.1% from $9.6 million in Q1 2025.
  • Gross margin fell to 61.5% from 62.8%, which the company attributed to production timing and tariff-related charges.
  • Net loss was $0.8 million, or $(0.02) per diluted share, compared with $1.2 million, or $(0.03), a year earlier.
  • Full year 2026 guidance was reiterated, not changed: net revenues of $47.5 million to $50.0 million and cash on hand of $8.8 million at March 31, 2026.

The filing

CompanyKORU Medical Systems, Inc. (KRMD)
Form8-K, current report
Filed with the SECMay 6, 2026, 4:02 PM ET
Accession number0001161697-26-000107

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.